Diadema Partners »

Cybin shares owned by Diadema Partners

Quarter-by-quarter ownership of Cybin (HELP) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 300k 6.61

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Cybin

VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Rosalind Advisors
Sphera Funds Management
Acorn Capital Advisors
DCF Advisers
Sio Capital Management
Morgan Stanley
Nan Fung Group Holdings
Boxer Capital Management
Citadel Advisors
Logos Global Management
Susquehanna International

View all funds holding Cybin